S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Start Premium Trial||Register For Free|
|P||F||Fund Financial Data (13,000+ funds)|
|P||F||Stock Financial Data (7,000+ stocks)|
|P||F||Stock and Fund Screeners (basic)|
|P||F||Investing Articles and Market Commentary|
|P||F||Articles Archive (>30 days)|
|P||F||Discuss (dozens of stock, fund, bond, and general bulletin boards)|
|P||F||Portfolio Manager (basic)|
|P||F||Morningstar Investment Classroom|
|P||F||Access Your Portfolio Anytime, Anywhere via Your Mobile Device|
|P||Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)|
|P||Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)|
|P||Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)|
|P||Portfolio Monitor (monthly and on-demand personalized portfolio statements)|
|P||Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)|
|P||Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters|
|P||Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)|
|P||Discounts on Morningstar newsletters, books, seminars, and more|
Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.
Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.
|Novogen Selected to Present at Cavendish Global Health Impact Forum (2014/3/10)|
|Novogen Appoints New Board Members and Strategic Advisor to Support Transition to Clinical Development and Growing International Presence (2014/3/4)|
|Novogen to Present at 2nd Annual Sachs Cancer Bio Partnering & Investment Forum in New York (2014/3/12)|
|Novogen and CanTx Experimental Drug, Trx-1, Proves Effective in Vivo (2014/3/18)|
|Novogene Acquires an Illumina HiSeq X Ten Sequencing System (2014/2/13)|
|Novogen Files Suite of Patents for Anti-Tropomyosin Drug Technology (2013/11/26)|
|Novogen Launches Joint Venture Aimed At Developing Drugs to Fight Ovarian Cancer ()|
|Novogen Announces Key Appointments to Drive Development of Anti-Tropomyosin Drug Platform (2014/2/3)|
|Novogen to Present at Biotech Showcase™ 2014 ()|
|Novogen Announces Establishment of Global Collaboration to Drive The Development of Drugs to Treat Brain Cancer (2013/12/20)|
Click above to view more mutual fund data and stats for nvgn - Novogen Ltd. ADR.